$IVAC
INTEVAC INC

2023 Q2 Form 10-Q Financial Statement

#000119312523135896 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $11.54M $4.445M
YoY Change 159.66% -72.63%
Cost Of Revenue $6.823M $3.722M
YoY Change 83.32% -71.78%
Gross Profit $4.719M $723.0K
YoY Change 552.7% -76.3%
Gross Profit Margin 40.89% 16.27%
Selling, General & Admin $5.200M $4.249M
YoY Change 22.38% -28.59%
% of Gross Profit 110.19% 587.69%
Research & Development $3.973M $5.660M
YoY Change -29.81% 55.49%
% of Gross Profit 84.19% 782.85%
Depreciation & Amortization $344.0K $445.0K
YoY Change -22.7% -43.67%
% of Gross Profit 7.29% 61.55%
Operating Expenses $9.173M $9.909M
YoY Change -7.43% 3.43%
Operating Profit -$4.454M -$9.186M
YoY Change -51.51% 40.67%
Interest Expense $632.0K -$24.00K
YoY Change -2733.33% -340.0%
% of Operating Profit
Other Income/Expense, Net $40.00K $16.00K
YoY Change 150.0% -20.0%
Pretax Income -$3.782M -$7.694M
YoY Change -50.84% 18.92%
Income Tax $386.0K $26.00K
% Of Pretax Income
Net Earnings -$3.891M -$7.855M
YoY Change -50.46% 20.85%
Net Earnings / Revenue -33.71% -176.72%
Basic Earnings Per Share -$0.15 -$0.32
Diluted Earnings Per Share -$0.15 -$316.7K
COMMON SHARES
Basic Shares Outstanding 25.78K 24.80K
Diluted Shares Outstanding 25.78K 24.80K

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $68.07M $107.0M
YoY Change -36.36% 118.76%
Cash & Equivalents $52.79M $4.372M
Short-Term Investments $15.28M $8.941M
Other Short-Term Assets $2.244M $1.778M
YoY Change 26.21% -1.22%
Inventory $43.67M $8.908M
Prepaid Expenses
Receivables $21.89M $17.05M
Other Receivables $0.00 $0.00
Total Short-Term Assets $135.9M $134.7M
YoY Change 0.86% 50.69%
LONG-TERM ASSETS
Property, Plant & Equipment $7.319M $7.338M
YoY Change -0.26% -59.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $15.97M $9.407M
YoY Change 69.74% 141.21%
Other Assets $4.969M $6.192M
YoY Change -19.75% -1.71%
Total Long-Term Assets $32.14M $22.94M
YoY Change 40.13% -18.66%
TOTAL ASSETS
Total Short-Term Assets $135.9M $134.7M
Total Long-Term Assets $32.14M $22.94M
Total Assets $168.0M $157.7M
YoY Change 6.57% 34.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.31M $3.915M
YoY Change 214.41% 39.82%
Accrued Expenses $4.303M $9.478M
YoY Change -54.6% -15.38%
Deferred Revenue $2.959M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.78M $28.71M
YoY Change -10.2% 105.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $21.38M $3.124M
YoY Change 584.31% -51.94%
Total Long-Term Liabilities $21.38M $3.124M
YoY Change 584.31% -51.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.78M $28.71M
Total Long-Term Liabilities $21.38M $3.124M
Total Liabilities $47.16M $31.84M
YoY Change 48.13% 55.3%
SHAREHOLDERS EQUITY
Retained Earnings -$57.08M
YoY Change
Common Stock $207.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $29.55M
YoY Change
Treasury Stock Shares $5.087K
Shareholders Equity $120.8M $125.8M
YoY Change
Total Liabilities & Shareholders Equity $168.0M $157.7M
YoY Change 6.57% 34.06%

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$3.891M -$7.855M
YoY Change -50.46% 20.85%
Depreciation, Depletion And Amortization $344.0K $445.0K
YoY Change -22.7% -43.67%
Cash From Operating Activities -$23.60M -$4.050M
YoY Change 482.74% -260.08%
INVESTING ACTIVITIES
Capital Expenditures $4.005M -$618.0K
YoY Change -748.06% 157.5%
Acquisitions
YoY Change
Other Investing Activities $12.17M -$891.0K
YoY Change -1465.99% -595.0%
Cash From Investing Activities $8.166M -$1.509M
YoY Change -641.15% 2055.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $835.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -689.0K 898.0K
YoY Change -176.73% -16.85%
NET CHANGE
Cash From Operating Activities -23.60M -4.050M
Cash From Investing Activities 8.166M -1.509M
Cash From Financing Activities -689.0K 898.0K
Net Change In Cash -16.11M -4.661M
YoY Change 245.72% -231.67%
FREE CASH FLOW
Cash From Operating Activities -$23.60M -$4.050M
Capital Expenditures $4.005M -$618.0K
Free Cash Flow -$27.61M -$3.432M
YoY Change 704.37% -223.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001001902
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-04-01
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
0-26946
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
INTEVAC, INC.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3125814
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
3560 Bassett Street
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95054
CY2023Q2 dei City Area Code
CityAreaCode
408
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
986-9888
CY2023Q2 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q2 dei Trading Symbol
TradingSymbol
IVAC
CY2023Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25924280
CY2023Q2 ivac Notes Receivable Numberof Installments
NotesReceivableNumberofInstallments
3
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
15823000
CY2023Q2 us-gaap Inventory Net
InventoryNet
43665000
CY2022Q4 us-gaap Inventory Net
InventoryNet
30003000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2244000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1898000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
135868000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
142169000
CY2023Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
15967000
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
17585000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
785000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
786000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7319000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3658000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2830000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3390000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
76000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
42000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1056000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1090000
CY2023Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
4184000
CY2022Q4 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
4381000
CY2023Q2 us-gaap Assets
Assets
168009000
CY2022Q4 us-gaap Assets
Assets
173059000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3214000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3404000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12309000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11610000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52791000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68904000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2998000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3087000
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
15283000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
25541000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2023Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
21885000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4303000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5430000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2959000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2444000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
25783000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25975000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
798000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1417000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
20580000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
22215000
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
21378000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
23632000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
26000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
26000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
207463000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
206355000
CY2023Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5087
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5087
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
29551000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
29551000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-193000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57076000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53185000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
120848000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
123452000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
168009000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
173059000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11542000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4445000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6823000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3722000
CY2023Q2 us-gaap Gross Profit
GrossProfit
4719000
CY2022Q2 us-gaap Gross Profit
GrossProfit
723000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3973000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4160000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5200000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4249000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
9173000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
8409000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4454000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7686000
CY2023Q2 ivac Interest Income And Other Income Expense
InterestIncomeAndOtherIncomeExpense
672000
CY2022Q2 ivac Interest Income And Other Income Expense
InterestIncomeAndOtherIncomeExpense
-8000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3782000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7694000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
386000
CY2022Q2 ivac Straight Line Rent Adjustments And Amortization Of Lease Incentives
StraightLineRentAdjustmentsAndAmortizationOfLeaseIncentives
-198000
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
65000
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4168000
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-7720000
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
277000
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-135000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3891000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7855000
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.16
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.16
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.31
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.31
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.01
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.01
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25781
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25781
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24800
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24800
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3891000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7855000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
169000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-174000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
10000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-33000
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
179000
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-207000
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0
CY2022Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
179000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-207000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3712000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8062000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3891000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-7855000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
344000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
445000
CY2023Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
61000
CY2022Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-17000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1581000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
-1036000
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1453000
CY2023Q2 ivac Straight Line Rent Adjustments And Amortization Of Lease Incentives
StraightLineRentAdjustmentsAndAmortizationOfLeaseIncentives
-249000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4445000
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
197000
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6000
CY2023Q2 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
21491000
CY2022Q2 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-3130000
CY2023Q2 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-19710000
CY2022Q2 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
3805000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23601000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4050000
CY2023Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1989000
CY2022Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
6525000
CY2023Q2 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
14095000
CY2022Q2 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
5634000
CY2023Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
65000
CY2022Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2023Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4005000
CY2022Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
618000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8166000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1509000
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
835000
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1033000
CY2023Q2 ivac Payment Of Acquisition Related Contingent Consideration
PaymentOfAcquisitionRelatedContingentConsideration
250000
CY2022Q2 ivac Payment Of Acquisition Related Contingent Consideration
PaymentOfAcquisitionRelatedContingentConsideration
0
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1274000
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
135000
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-689000
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
898000
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10000
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-33000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16114000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4694000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
69690000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
103514000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53576000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98820000
CY2022Q2 us-gaap Product Warranty Expense
ProductWarrantyExpense
171000
CY2023Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
100000
CY2022Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
36000
CY2023Q2 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
11000
CY2022Q2 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
38000
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
177000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2023Q2 ivac Equity Based Compensation Discontinued Operation
EquityBasedCompensationDiscontinuedOperation
-260000
CY2022Q2 ivac Equity Based Compensation Discontinued Operation
EquityBasedCompensationDiscontinuedOperation
-330000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11542000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4445000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11542000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
26024000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
27105000
CY2023Q2 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-1081000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
120700000
CY2023Q2 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
we also refer to as total backlog. We expect to recognize approximately 38% of our remaining performance obligations as revenue in 2023 and 21% in 2024, 0% in 2025 and 41% in 2026.
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
31133000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19116000
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11142000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9499000
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1390000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1388000
CY2023Q2 us-gaap Inventory Net
InventoryNet
43665000
CY2022Q4 us-gaap Inventory Net
InventoryNet
30003000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
CY2023Q2 ivac Share Based Compensation Arrangement By Share Based Payment Award Options Offering Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOfferingPeriod
P2Y
CY2023Q2 ivac Purchase Intervals Of Series
PurchaseIntervalsOfSeries
P6M
CY2023Q2 ivac Maximum Employee Salary Withholdings For Purchase Of Common Stock Under Terms Of Espp
MaximumEmployeeSalaryWithholdingsForPurchaseOfCommonStockUnderTermsOfEspp
0.50
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Repurchase Obligation Amount
EmployeeStockOwnershipPlanESOPRepurchaseObligationAmount
25000
CY2023Q2 ivac Maximum Product Warranty Range
MaximumProductWarrantyRange
P24M
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
163000
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
346000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1581000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
-1036000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
383099
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.07
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11718
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.68
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
52313
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.15
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
319068
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.36
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
302132
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.45
CY2023Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
131303
CY2023Q2 ivac Minimum Product Warranty Range
MinimumProductWarrantyRange
P12M
CY2023Q2 us-gaap Product Warranty Expense
ProductWarrantyExpense
97000
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
75
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
249000
CY2023Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
177000
CY2022Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
163000
CY2023Q2 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
0
CY2022Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
0
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
177000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
163000
CY2023Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
785000
CY2023Q2 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
785000
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
84356000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
321000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
84041000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
112514000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
484000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
112030000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
48613000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
48452000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
16121000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
15967000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
64734000
CY2023Q2 us-gaap Debt Securities
DebtSecurities
64419000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2023Q2 us-gaap Debt Securities Available For Sale Term
DebtSecuritiesAvailableForSaleTerm
P3Y
CY2018Q3 ivac Stock Repurchase Program Acquired Authorized Amount
StockRepurchaseProgramAcquiredAuthorizedAmount
10000000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
39460000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
200000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
6910000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
121000
CY2023Q2 us-gaap Average Remaining Maturity Of Foreign Currency Derivatives1
AverageRemainingMaturityOfForeignCurrencyDerivatives1
P30D
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
123452000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
801000
CY2023Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1274000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1581000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3891000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
179000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
120848000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
134015000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1033000
CY2022Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-135000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-1036000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7855000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-207000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
125815000
CY2013Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000
CY2018Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
40000000
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
10400000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4168000
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-7720000
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
277000
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-135000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3891000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7855000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25781
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24800
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25781
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24800
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.16
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.16
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.31
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.31
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.01
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.01
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
386000
CY2023Q2 us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
224000
CY2022Q2 us-gaap Income Loss From Subsidiaries Tax Expense Benefit
IncomeLossFromSubsidiariesTaxExpenseBenefit
26000
CY2023Q2 ivac Profit Threshold Upto Which Corporate Alternative Minimum Tax Is Not Applicable
ProfitThresholdUptoWhichCorporateAlternativeMinimumTaxIsNotApplicable
1000000000
CY2022 ivac Other Employee Benefits Expense
OtherEmployeeBenefitsExpense
693000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1200000
CY2022Q1 us-gaap Other Commitment
OtherCommitment
665000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2100000
CY2022Q1 ivac Operating Lease First Instalment Payments
OperatingLeaseFirstInstalmentPayments
308000
CY2022Q1 ivac Number Of Operating Lease Payments
NumberOfOperatingLeasePayments
7
CY2022Q1 ivac Operating Lease Quarterly Instalment Payments
OperatingLeaseQuarterlyInstalmentPayments
259000
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1200000
CY2022Q1 us-gaap Other Commitment
OtherCommitment
665000
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
37000
CY2022Q1 us-gaap Restructuring Reserve
RestructuringReserve
1023000
CY2022Q2 ivac Provision For Restructuring Charges Associated With Photonics Sale A
ProvisionForRestructuringChargesAssociatedWithPhotonicsSaleA
114000
CY2022Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
265000
CY2022Q2 ivac Restructuring Reserve Settled Without Cash
RestructuringReserveSettledWithoutCash
75000
CY2022Q2 us-gaap Restructuring Reserve
RestructuringReserve
797000
CY2023Q2 us-gaap Restructuring Costs
RestructuringCosts
1200000
CY2023Q2 ivac Savings In Stock Based Compensation Pursuant To Restructuring
SavingsInStockBasedCompensationPursuantToRestructuring
1300000
CY2023Q2 ivac Cost Of Disposal Of Fixed Assets
CostOfDisposalOfFixedAssets
1500000
CY2023Q2 ivac Inventory Writeoff
InventoryWriteoff
755000
CY2023Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.06
CY2023Q2 ivac Expected Decrease In Expenses Due To Reduction In Workforce
ExpectedDecreaseInExpensesDueToReductionInWorkforce
2100000
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
250000
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
250000
CY2022Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y3M18D
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34000
CY2022Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1000000

Files In Submission

Name View Source Status
0001193125-23-135896-index-headers.html Edgar Link pending
0001193125-23-135896-index.html Edgar Link pending
0001193125-23-135896.txt Edgar Link pending
0001193125-23-135896-xbrl.zip Edgar Link pending
d383537d10q.htm Edgar Link pending
d383537dex101.htm Edgar Link pending
d383537dex311.htm Edgar Link pending
d383537dex312.htm Edgar Link pending
d383537dex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ivac-20230401.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
ivac-20230401_def.xml Edgar Link unprocessable
ivac-20230401_cal.xml Edgar Link unprocessable
ivac-20230401_pre.xml Edgar Link unprocessable
ivac-20230401_lab.xml Edgar Link unprocessable
d383537d10q_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable